Literature DB >> 24803166

Spatiotemporal pattern of TRAF3 expression after rat spinal cord injury.

Ya Wu1, Minqian Zheng, Siqing Wang, Changzhi Song, Chuanbin Wang, Yueping Xiao, Lei Xu, Xiaozu Xu.   

Abstract

TNF receptor associated factor 3 (TRAF3), a member of the TRAF family of intracellular signaling proteins, can directly influence the phosphorylation status and activation of c-Jun N-terminal kinase, participating in CD40-induced apoptosis in carcinoma. However, its expression profile and function are still unclear in spinal cord injury (SCI). In this study, we performed an acute spinal cord contusion injury model in adult rats and detected the dynamic change patterns of TRAF3 expression in spinal cord. Western blot and immunohistochemistry revealed a striking upregulation of TRAF3 after SCI. Double immunofluorescence staining prompted that TRAF3 immunoreactivity was found in neurons rather than astrocytes. Moreover, co-localization of TRAF3/active caspase-3 was detected in neuronal nuclei. To further investigate the function of TRAF3, a neuronal cell line PC12 was employed to establish an apoptosis model in vitro. We analyzed the association of TRAF3 with active caspase-3 on PC12 cells by western blot and immunofluorescent labeling, which was parallel with the data in vivo. Additionally, knocking TRAF3 down with siRNA demonstrated the probable pro-apoptotic role of TRAF3 in the process of neuronal apoptosis. To summarize, we firstly uncover the temporal and spatial expression changes of TRAF3 in SCI. Our data suggest that TRAF3 might be implicated in central nervous system pathophysiology after SCI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24803166     DOI: 10.1007/s10735-014-9575-2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  59 in total

1.  A novel RING finger protein interacts with the cytoplasmic domain of CD40.

Authors:  H M Hu; K O'Rourke; M S Boguski; V M Dixit
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

2.  A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation.

Authors:  N T Georgopoulos; L P Steele; M J Thomson; P J Selby; J Southgate; L K Trejdosiewicz
Journal:  Cell Death Differ       Date:  2006-01-20       Impact factor: 15.828

3.  Angelicin induces apoptosis through intrinsic caspase-dependent pathway in human SH-SY5Y neuroblastoma cells.

Authors:  Md Ataur Rahman; Nam-Ho Kim; Haijie Yang; Sung-Oh Huh
Journal:  Mol Cell Biochem       Date:  2012-07-06       Impact factor: 3.396

4.  Spatiotemporal patterns and essential role of TNF receptor-associated factor 5 expression after rat spinal cord Injury.

Authors:  Weipeng Huan; Xiujie Wu; Shuangwei Zhang; Yin Zhao; Hua Xu; Na Wang; Honghui Li; Hailei Chen; Haixiang Wei; Youhua Wang
Journal:  J Mol Histol       Date:  2012-04-08       Impact factor: 2.611

5.  Immunohistochemical localization of caspase-3, caspase-9 and Bax in U87 glioblastoma xenografts.

Authors:  Otilia Zarnescu; Felix Mircea Brehar; Mihaela Chivu; Alexandru Vladimir Ciurea
Journal:  J Mol Histol       Date:  2008-09-24       Impact factor: 2.611

6.  Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3.

Authors:  Bo Zhong; Xikui Liu; Xiaohu Wang; Xindong Liu; Hongxiu Li; Bryant G Darnay; Xin Lin; Shao-Cong Sun; Chen Dong
Journal:  Sci Signal       Date:  2013-05-14       Impact factor: 8.192

7.  A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.

Authors:  J Blake Marriott; Ian A Clarke; Anna Czajka; Keith Dredge; Kay Childs; Hon-Wah Man; Peter Schafer; Sowmya Govinda; George W Muller; David I Stirling; Angus G Dalgleish
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

8.  MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades.

Authors:  Siqi Liu; Jueqi Chen; Xin Cai; Jiaxi Wu; Xiang Chen; You-Tong Wu; Lijun Sun; Zhijian J Chen
Journal:  Elife       Date:  2013-08-14       Impact factor: 8.140

9.  A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes.

Authors:  Wai W Lin; Joanne M Hildebrand; Gail A Bishop
Journal:  Front Immunol       Date:  2013-12-20       Impact factor: 7.561

10.  Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo.

Authors:  Junfang Wu; Giorgi Kharebava; Chunshu Piao; Bogdan A Stoica; Michael Dinizo; Boris Sabirzhanov; Marie Hanscom; Kelsey Guanciale; Alan I Faden
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more
  5 in total

1.  Nuclear TRAF3 is a negative regulator of CREB in B cells.

Authors:  Nurbek Mambetsariev; Wai W Lin; Laura L Stunz; Brett M Hanson; Joanne M Hildebrand; Gail A Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

2.  The Chx10-Traf3 Knockout Mouse as a Viable Model to Study Neuronal Immune Regulation.

Authors:  Jami M Gurley; Grzegorz B Gmyrek; Elizabeth A Hargis; Gail A Bishop; Daniel J J Carr; Michael H Elliott
Journal:  Cells       Date:  2021-08-12       Impact factor: 7.666

Review 3.  TRAF3 as a powerful and multitalented regulator of lymphocyte functions.

Authors:  Gail A Bishop
Journal:  J Leukoc Biol       Date:  2016-05-06       Impact factor: 4.962

Review 4.  TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.

Authors:  Gail A Bishop; Laura L Stunz; Bruce S Hostager
Journal:  Front Immunol       Date:  2018-09-24       Impact factor: 7.561

5.  TRAF3 mediates neuronal apoptosis in early brain injury following subarachnoid hemorrhage via targeting TAK1-dependent MAPKs and NF-κB pathways.

Authors:  Yan Zhou; Tao Tao; Guangjie Liu; Xuan Gao; Yongyue Gao; Zong Zhuang; Yue Lu; Han Wang; Wei Li; Lingyun Wu; Dingding Zhang; Chunhua Hang
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.